Navigation Links
Singapore scientists synthesize gold to shed light on cells' inner workings
Date:4/16/2009

Highly fluorescent gold nanoclusters for sub-cellular imaging have been synthesized by researchers at the Institute of Bioengineering and Nanotechnology (IBN), one of the research institutes of Singapore's A*STAR (Agency for Science, Technology and Research).

Measuring less than 1 nanometer in diameter, IBN's gold clusters are much smaller than currently available nanoscale imaging technologies such as semiconducting quantum dots, which are usually at least 3 nanometers in size. 1 nanometer is approximately 5 orders smaller than the breadth of a human hair (~105 nm).

Unlike quantum dots, the gold nanoclusters are suitable for use within the body because they do not contain toxic metals such as cadmium and lead.

This invention, which has broad implications for biolabeling and disease diagnosis, was recently published in the Journal of the American Chemical Society, 131 (2009) 888-889.

The gold nanoclusters' sub-nanometer size makes it easy to target the nucleus inside the cell for sub-cellular biolabeling and bioimaging. Tracking the cell nucleus can help scientists monitor the fundamental life processes of healthy DNA replication and any genomic changes. With improved bioimaging at the cell nucleus, scientists can also study the effectiveness of drug and gene therapies.

"Gold nanoclusters have promising characteristics for applications in vivo. Our materials are smaller, less toxic and more biocompatible than the existing inorganic fluorescent quantum dot tags. The red fluorescence of the nanoclusters enhances biomedical images of the body greatly as there is reduced background fluorescence and better tissue penetration," said IBN Postdoctoral Fellow Jianping Xie, Ph.D.

Synthesized via a single-step reaction at body temperature (37C), the gold nanoclusters are formed with a commercially available common protein such as bovine serum albumin (BSA). "The protein holds and interacts with gold ions in aqueous solution. We are able to use this protein to provide a scaffold for the formation of gold nanoclusters," explained Yuangang Zheng, Ph.D., IBN Senior Research Scientist.

The synthesis of the gold nanoclusters does not involve toxic chemicals or high temperatures. A single reaction with a protein is all that is required to produce scalable quantities of stable gold nanoclusters.

IBN's gold nanoclusters are stable in aqueous solution as well as in the solid form, which facilitates their storage and distribution. Besides the low cost of the required reagents, the preparation of the gold nanoclusters also adopts an environmentally friendly method that does not involve toxic chemicals or high temperatures. In addition, the simple synthesis technique can be scaled up easily for mass production.

"We are inspired by nature's ability to create elegant and functional materials. Our process is similar to biomineralization in nature that is found in the formation of bones and shells: where functional proteins mostly interact with sequestered inorganic ions to provide scaffolds for mineral formation," said IBN Principal Investigator and Executive Director Jackie Y. Ying, Ph.D. "There is a significant potential for our technology to impact biological and medical research, where our gold nanoclusters can significantly enhance the details available for precision bioimaging in medical diagnosis and treatment."


'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Related biology news :

1. Singapore researchers first to transform carbon dioxide into methanol
2. First tri-continuous mesoporous Silica complex structure developed in Singapore
3. Regulatory molecule for tumor formation or suppression identified by Singapore, US researchers
4. The Earth Observatory of Singapore devoted to the study of earth sciences officially opens
5. Singapore research organisations team up to advance drug discovery using brain tumor stem cells
6. Singapore-US scientists first to develop revolutionary microchip that uses 30 times less energy
7. NTU undergrad is first Singapore champion of an internationally acclaimed engineering competition
8. Singapore research team first place in Brain-Computer Interface contest
9. Singapore opens Fusionopolis, its second major R&D hub in 5 years
10. Singapores BIOPOLIS and FUSIONOPOLIS on stage in Boston this week
11. Ludwig Institute for Cancer Research to set up its first Asian branch in Singapore
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... Feb. 2, 2016  BioMEMS devices deployed ... focused on medical screening and diagnostic applications, ... Wearable devices that facilitate and assure continuous ... movement are being bolstered through new opportunities ... signal acquisition coupled with wireless connectivity and ...
(Date:2/2/2016)... 2, 2016 Technology Enhancements Accelerate Growth of X-ray ... the digital and computed radiography markets in ... Indonesia (TIM). It provides an ... as well as regional market drivers and restraints. The ... penetration and market attractiveness, both for digital and computed ...
(Date:2/1/2016)... , February 1, 2016 Rising ... to drive global touchfree intuitive gesture control market ... Rising sales of consumer electronics coupled with new ... market size through 2020   ... coupled with new technological advancements to drive global touchfree ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... Australian-US drug discovery and development company, Novogen Limited ... a new Chairman, Mr John O,Connor , and new ... James Garner , has also been formally appointed ... CEO, Mr Iain Ross , will resume his role ... James Garner , has also been formally appointed to the ...
(Date:2/4/2016)... ... , ... Shimadzu Scientific Instruments will showcase several new products, ... sessions, and present on the analysis of mycotoxins and medical cannabis at the ... at the Georgia World Congress Center in Atlanta, Georgia. , Attendees should ...
(Date:2/4/2016)... MENLO PARK, Calif. , Feb. 4, 2016 /PRNewswire/ ... "Company"), a biopharmaceutical company focused on the development and commercialization ... at the 18 th Annual BIO CEO & ... a.m. EST in New York, NY . ... will provide an update on the ongoing clinical trial of ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... China , today announced that the ... February 4, 2016 a preliminary non-binding proposal letter, dated ... V-Ming ( Shanghai ) Investment Holdings Co., ... Shenzhen ) Fund Management Co., Ltd., Beijing ...
Breaking Biology Technology: